These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7961566)

  • 1. The role of 5-HT3-like receptors in the action of clozapine.
    Wang RY; Ashby CR; Edwards E; Zhang JY
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():23-6. PubMed ID: 7961566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the A10 dopamine system: electrophysiological studies of the role of 5-HT3-like receptors.
    Wang RY; Ashby CR; Zhang JY
    Behav Brain Res; 1996; 73(1-2):7-10. PubMed ID: 8788469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of various typical and atypical antipsychotic drugs on the suppressant action of 2-methylserotonin on medial prefrontal cortical cells in the rat.
    Ashby CR; Minabe Y; Edwards E; Wang RY
    Synapse; 1991 Jul; 8(3):155-61. PubMed ID: 1683017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of NMDA-receptor mediated response in the rat medial prefrontal cortical pyramidal cells by the 5-HT3 receptor agonist SR 57227A and 5-HT: intracellular studies.
    Liang X; Arvanov VL; Wang RY
    Synapse; 1998 Jul; 29(3):257-68. PubMed ID: 9635896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
    Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI
    J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limbic-prefrontal connectivity and clozapine.
    Knable MB; Weinberger DR
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():70-3. PubMed ID: 7961578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner.
    Rammes G; Eisensamer B; Ferrari U; Shapa M; Gimpl G; Gilling K; Parsons C; Riering K; Hapfelmeier G; Bondy B; Zieglgänsberger W; Holsboer F; Rupprecht R
    Mol Psychiatry; 2004 Sep; 9(9):846-58, 818. PubMed ID: 15024394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
    Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism.
    Chung YC; Li Z; Dai J; Meltzer HY; Ichikawa J
    Brain Res; 2004 Oct; 1023(1):54-63. PubMed ID: 15364019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential activation of cortical dopamine neurotransmission by clozapine: functional significance.
    Moghaddam B
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():27-9. PubMed ID: 7961567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing sertindole to other new generation antipsychotics on preferential dopamine output in limbic versus striatal projection regions: mechanism of action.
    Hertel P
    Synapse; 2006 Dec; 60(7):543-52. PubMed ID: 16952163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
    Kuroki T; Nagao N; Nakahara T
    Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of typical and atypical antipsychotic drugs on the stimulation of phosphoinositide hydrolysis produced by the 5-HT3 receptor agonist 2-methyl-serotonin.
    Edwards E; Ashby CR; Wang RY
    Brain Res; 1991 Apr; 545(1-2):276-8. PubMed ID: 1677603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.
    Herrick-Davis K; Grinde E; Teitler M
    J Pharmacol Exp Ther; 2000 Oct; 295(1):226-32. PubMed ID: 10991983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.
    Millan MJ; Newman-Tancredi A; Audinot V; Cussac D; Lejeune F; Nicolas JP; Cogé F; Galizzi JP; Boutin JA; Rivet JM; Dekeyne A; Gobert A
    Synapse; 2000 Feb; 35(2):79-95. PubMed ID: 10611634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors.
    Cussac D; Duqueyroix D; Newman-Tancredi A; Millan MJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):168-77. PubMed ID: 12110994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine hydroxylase mRNA and protein are down-regulated by chronic clozapine in both the mesocorticolimbic and the nigrostriatal systems.
    Tejedor-Real P; Faucon Biguet N; Dumas S; Mallet J
    J Neurosci Res; 2003 Apr; 72(1):105-15. PubMed ID: 12645084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional antagonistic properties of clozapine at the 5-HT3 receptor.
    Hermann B; Wetzel CH; Pestel E; Zieglgänsberger W; Holsboer F; Rupprecht R
    Biochem Biophys Res Commun; 1996 Aug; 225(3):957-60. PubMed ID: 8780717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-16924 [(R)-2-[1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]- pyrrolidin-3yl]-1-(4-fluorophenyl)-ethanone], a novel, potential antipsychotic with marked serotonin1A agonist properties: III. Anxiolytic actions in comparison with clozapine and haloperidol.
    Millan MJ; Brocco M; Gobert A; Schreiber R; Dekeyne A
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1002-14. PubMed ID: 10027837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.